Monoclonal Antibody Shows Promise in Childhood Brain Tumor

Tumors shrank or disappeared in some patients with advanced neuroblastoma in a Phase 1 study of an immune therapy manufactured at St. Jude Children's Research Hospital.

Tumors shrank or disappeared and disease progression 

 http://www.dddmag.com/news/2014/05/monoclonal-antibody-shows-promise-childhood-brain-tumor

Monoclonal Antibody Shows Promise in Childhood Brain Tumor

THANKS AND REGARD'S
DR ANTHONY MELVIN CRASTO Ph.D
amcrasto@gmail.com

MOBILE-+91 9323115463

GLENMARK SCIENTIST ,  INDIA
web link

ABOUTME

BRAND ANTHONYCRASTO

COLLECTION OF SITE LINKS

http://amcrasto.bravesites.com/

http://anthonycrasto.jimdo.com/

Congratulations! Your presentation titled "Anthony Crasto Glenmark scientist, helping millions with websites" has just crossed MILLION views.

アンソニー     安东尼   Энтони    안토니     أنتوني

join my process development group on google

organic-process-development group

you can post articles and will be administered by me on the google group which is very popular across the world

https://sites.google.com/site/amcrasto/

SKILLPAGES

MIXXT

APNACIRCLE

LinkedIn group

SYNTHETIC ORGANIC CHEMISTRY

 
blogs are 

• Green Chemistry International,  
• Eurekamoments in Organic Chemistry ,   
• WIX CHEMISTRY BLOG , 
• Drug regulatory affairs international 
• ORGANIC CHEMISTRY SELECT
• ORGANIC SPECTROSCOPY INTERNATIONAL 
• ORGANIC SYNTHESIS INTERNATIONAL 
• ORGANIC CHEMISTRY INTERNATIONAL

MY BLOG ON MED CHEM
New Drug Approvals
ALL ABOUT DRUGS
WORLD DRUG TRACKER
MEDICINAL CHEM INTERNATIONAL
DRUG SYN INTERNATIONAL
SCALEUP OF DRUGS
ALL FOR DRUGS ON WEB
http://scholar.google.co.uk/citations?user=bxm3kYkAAAAJ

MY CHINA AND JAPAN BLOGS

http://amcrasto.blog.fc2.com/

http://blog.sina.com.cn/u/5030268874

http://ameblo.jp/medchem-amcrasto/

VIETNAM
http://me.zing.vn/u/amcrasto
ICELAND
http://amcrasto.bland.is/
RUSSIA
http://www.100zakladok.ru/amcrasto/
http://bobrdobr.ru/people/amcrasto/

 

MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: PHARMA DEALS DURING MARCH 2014Following on from l...

MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: PHARMA DEALS DURING MARCH 2014
Following on from l...: PHARMA DEALS DURING MARCH 2014 Following on from  last month's Deal Watch , which included four transactions of over $1bn, Marc...

MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: BIOTECH IPOs: WHAT ENTREPRENEURS CAN LEARN FROM A ...

MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: BIOTECH IPOs: WHAT ENTREPRENEURS CAN LEARN FROM A ...: BIOTECH IPOs: WHAT ENTREPRENEURS CAN LEARN FROM A BANNER YEAR (Part 1 out of 2) The data is in, and there is no question that 2013...

MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: BIOSIMILARS MARKET IS NOT EQUIVALENT TO GENERICS M...

MANAGEMENT SOLUTIONS GROUP LatAm - Gestión de Organizaciones de Salud, Farma & Biotech: BIOSIMILARS MARKET IS NOT EQUIVALENT TO GENERICS M...: BIOSIMILARS MARKET IS NOT EQUIVALENT TO GENERICS MARKET by Ben Comer For years now, the increased spend on healthcare in the U.S....

Tezacitabine « New Drug Approvals

Tezacitabine « New Drug Approvals:



'via Blog this'

Rucaparib, PF-01367338 for the treatment of patients with advanced ovarian cancer and in patients with locally advanced or metastatic breast cancer. « New Drug Approvals

Rucaparib, PF-01367338 for the treatment of patients with advanced ovarian cancer and in patients with locally advanced or metastatic breast cancer. « New Drug Approvals:



'via Blog this'

DASABUVIR, ABT 333 for the chronic Hepatitis C treatment. « New Drug Approvals

DASABUVIR, ABT 333 for the chronic Hepatitis C treatment. « New Drug Approvals:



'via Blog this'